RCAS1 Monoclonal antibody
RCAS1 Monoclonal Antibody for ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human, mouse, rat
Applications
WB, IF, ELISA
Conjugate
Unconjugated
CloneNo.
4H8A12
Cat no : 66170-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Recommended dilution
Application | Dilution |
---|---|
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 1 publications below |
IF | See 1 publications below |
Product Information
66170-1-Ig targets RCAS1 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | mouse |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | RCAS1 fusion protein Ag2905 相同性解析による交差性が予測される生物種 |
Full Name | estrogen receptor binding site associated, antigen, 9 |
Calculated molecular weight | 213 aa, 24 kDa |
Observed molecular weight | 34 kDa |
GenBank accession number | BC017729 |
Gene symbol | RCAS1 |
Gene ID (NCBI) | 9166 |
RRID | AB_2881565 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Estrogen receptor-binding fragment-associated antigen 9 (EBAG9) gene was identified as an estrogen-responsive gene. The gene product, receptor-binding cancer antigen expressed on SiSo cells (RCAS1), is associated with aggressive characteristics and poor overall survival for 15 different human malignancies. The correlation between RCAS1 expression and several clinicopathological variables, including tumor size, clinical stage, invasion depth and lymph node metastasis highlights this molecule's clinical significance. Expression of RCAS1 in tumor cells plays an important role in evasion from host immune system resulting tumor progression, invasion and metastasis. Further exploration of RCAS1 biological function will facilitate development of novel therapeutic strategies that target RCAS1.
Publications
Species | Application | Title |
---|---|---|
Mol Med Rep RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylation |